{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:26:54Z","timestamp":1791498414657,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13054-019-2481-y","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:03:39Z","timestamp":1559034219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Procalcitonin levels in candidemia versus bacteremia: a systematic review"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1416-9993","authenticated-orcid":false,"given":"Andrea","family":"Cortegiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Misseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariachiara","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Giarratano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Martin-Loeches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Einav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"issue":"9","key":"2481_CR1","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00134-017-4731-2","volume":"43","author":"Matteo Bassetti","year":"2017","unstructured":"Bassetti M, Garnacho-Montero J, Calandra T, Kullberg B, Dimopoulos G, Azoulay E, et al. Intensive care medicine research agenda on invasive fungal infection in critically ill patients. Intensive Care Med. 2017;43:1225-38.","journal-title":"Intensive Care Medicine"},{"key":"2481_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ1194","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1\u201350.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"2481_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","volume":"24","author":"AJ Ullmann","year":"2018","unstructured":"Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24(Suppl 1):e1\u2013e38.","journal-title":"Clin Microbiol Infect"},{"key":"2481_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13054-016-1284-7","volume":"20","author":"A Cortegiani","year":"2016","unstructured":"Cortegiani A, Russotto V, Raineri SM, Giarratano A. The paradox of the evidence about invasive fungal infection prevention. Crit Care. 2016;20:114.","journal-title":"Crit Care"},{"key":"2481_CR5","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMra1315399","volume":"373","author":"BJ Kullberg","year":"2015","unstructured":"Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373:1445\u201356.","journal-title":"N Engl J Med"},{"key":"2481_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12281-017-0288-3","volume":"11","author":"A Cortegiani","year":"2017","unstructured":"Cortegiani A, Russotto V, Raineri SM, Gregoretti C, De Rosa FG, Giarratano A. Untargeted antifungal treatment strategies for invasive candidiasis in non-neutropenic critically ill patients: current evidence and insights. Curr Fungal Infect Rep. 2017;11:84\u201391.","journal-title":"Curr Fungal Infect Rep"},{"key":"2481_CR7","first-page":"CD004920","volume":"1","author":"A Cortegiani","year":"2016","unstructured":"Cortegiani A, Russotto V, Maggiore A, Attanasio M, Naro AR, Raineri SM, et al. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev. 2016;1:CD004920.","journal-title":"Cochrane Database Syst Rev"},{"key":"2481_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13054-016-1313-6","volume":"20","author":"T Calandra","year":"2016","unstructured":"Calandra T, Roberts JA, Antonelli M, Bassetti M, Vincent J-L. Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy. Crit Care. 2016;20:125.","journal-title":"Crit Care"},{"key":"2481_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00134-018-5363-x","volume":"45","author":"A Cortegiani","year":"2019","unstructured":"Cortegiani A, Misseri G, Chowdhary A. What\u2019s new on emerging resistant Candida species. Intensive Care Med. 2019;45:512\u20135.","journal-title":"Intensive Care Med"},{"key":"2481_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40560-018-0342-4","volume":"6","author":"A Cortegiani","year":"2018","unstructured":"Cortegiani A, Misseri G, Fasciana T, Giammanco A, Giarratano A, Chowdhary A. Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. J Intensive Care. 2018;6:69.","journal-title":"J Intensive Care"},{"issue":"1","key":"2481_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/jof4010027","volume":"4","author":"Cornelius Clancy","year":"2018","unstructured":"Clancy CJ, Nguyen MH. Non-culture diagnostics for invasive candidiasis: promise and unintended consequences. J Fungi (Basel). 2018;4:27.","journal-title":"Journal of Fungi"},{"key":"2481_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1001\/jama.2016.16535","volume":"317","author":"A Cortegiani","year":"2017","unstructured":"Cortegiani A, Russotto V, Giarratano A. Associations of antifungal treatments with prevention of fungal infection in critically ill patients without neutropenia. JAMA. 2017;317:311\u20132.","journal-title":"JAMA."},{"key":"2481_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13054-019-2449-y","volume":"23","author":"A Cortegiani","year":"2019","unstructured":"Cortegiani A, Misseri G, Giarratano A, Bassetti M, Eyre D. The global challenge of Candida auris in the intensive care unit. Crit Care. 2019;23:150.","journal-title":"Crit Care"},{"key":"2481_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/14787210.2019.1562335","volume":"17","author":"M Bassetti","year":"2019","unstructured":"Bassetti M, Russo A, Righi E, Dolso E, Merelli M, D'Aurizio F, et al. Role of procalcitonin in bacteremic patients and its potential use in predicting infection etiology. Expert Rev Anti-Infect Ther. 2019;17:99\u2013105.","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"2481_CR15","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/CCM.0000000000002953","volume":"46","author":"SW Lam","year":"2018","unstructured":"Lam SW, Bauer SR, Fowler R, Duggal A. Systematic review and meta-analysis of procalcitonin-guidance versus usual care for antimicrobial management in critically ill patients: focus on subgroups based on antibiotic initiation, cessation, or mixed strategies. Crit Care Med. 2018;46:684\u201390.","journal-title":"Crit Care Med"},{"key":"2481_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13054-018-2125-7","volume":"22","author":"Y Wirz","year":"2018","unstructured":"Wirz Y, Meier MA, Bouadma L, Luyt CE, Wolff M, Chastre J, et al. Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials. Crit Care. 2018;22:191.","journal-title":"Crit Care"},{"key":"2481_CR17","doi-asserted-by":"crossref","unstructured":"Cortegiani A, Russotto V, Raineri SM, Giarratano A.\u00a0Is it time to combine untargeted antifungal strategies to reach the goal of \u2018early\u2019 effective treatment? Crit Care. 2017;20:241.","DOI":"10.1186\/s13054-016-1404-4"},{"key":"2481_CR18","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1210\/jc.2002-021444","volume":"89","author":"ES Nylen","year":"2004","unstructured":"Nylen ES, White JC, Snider RHJ, Becker KL, Muller B. Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab. 2004;89:1512\u201325.","journal-title":"J Clin Endocrinol Metab"},{"key":"2481_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12916-017-0795-7","volume":"15","author":"R Sager","year":"2017","unstructured":"Sager R, Kutz A, Mueller B, Schuetz P. Procalcitonin-guided diagnosis and antibiotic stewardship revisited. BMC Med. 2017;15:15.","journal-title":"BMC Med"},{"key":"2481_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40560-017-0252-x","volume":"5","author":"SM Raineri","year":"2017","unstructured":"Raineri SM, Cortegiani A, Vitale F, Iozzo P, Giarratano A. Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence? J Intensive Care. 2017;5:58.","journal-title":"J Intensive Care"},{"key":"2481_CR21","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.diagmicrobio.2013.04.023","volume":"76","author":"Y-H Dou","year":"2013","unstructured":"Dou Y-H, Du J-K, Liu H-L, Shong X-D. The role of procalcitonin in the identification of invasive fungal infection-a systemic review and meta-analysis. Diagn Microbiol Infect Dis. 2013;76:464\u20139.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2481_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13054-016-1182-z","volume":"20","author":"A Spec","year":"2016","unstructured":"Spec A, Shindo Y, Burnham C-AD, Wilson S, Ablordeppey EA, Beiter ER, et al. T cells from patients with Candida sepsis display a suppressive immunophenotype. Crit Care. 2016;20:15.","journal-title":"Crit Care"},{"key":"2481_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.5152\/TJAR.2016.0013","volume":"44","author":"A Cortegiani","year":"2016","unstructured":"Cortegiani A, Russotto V, Raineri SM, Gregoretti C, Giarratano A. Dying with or because of invasive fungal infection? The role of immunity exhaustion on patient outcome. Turk J Anaesthesiol Reanim. 2016;44:285\u20136.","journal-title":"Turk J Anaesthesiol Reanim"},{"key":"2481_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13054-016-1378-2","volume":"20","author":"V Russotto","year":"2016","unstructured":"Russotto V, Cortegiani A, Raineri SM, Giarratano A. From bedside to bench: the missing brick for patients with fungal sepsis. Crit Care. 2016;20:191.","journal-title":"Crit Care"},{"key":"2481_CR25","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00134-006-0306-3","volume":"32","author":"PE Charles","year":"2006","unstructured":"Charles PE, Dalle F, Aho S, Quenot J-P, Doise J-M, Aube H, et al. Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients. Intensive Care Med. 2006;32:1577\u201383.","journal-title":"Intensive Care Med"},{"key":"2481_CR26","first-page":"425","volume":"60","author":"A Martini","year":"2010","unstructured":"Martini A, Gottin L, Menestrina N, Schweiger V, Simion D, Vincent J-L. Procalcitonin levels in surgical patients at risk of candidemia. J Inf Secur. 2010;60:425\u201330.","journal-title":"J Inf Secur"},{"key":"2481_CR27","first-page":"438","volume":"64","author":"Y Fu","year":"2012","unstructured":"Fu Y, Chen J, Cai B, Zhang J, Li L, Liu C, et al. The use of PCT, CRP, IL-6 and SAA in critically ill patients for an early distinction between candidemia and Gram positive\/negative bacteremia. J Inf Secur. 2012;64:438\u201340.","journal-title":"J Inf Secur"},{"key":"2481_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10238-012-0191-8","volume":"13","author":"H Brodska","year":"2013","unstructured":"Brodska H, Malickova K, Adamkova V, Benakova H, Stastna MM, Zima T. Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis. Clin Exp Med. 2013;13:165\u201370.","journal-title":"Clin Exp Med"},{"key":"2481_CR29","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1128\/JCM.02473-12","volume":"51","author":"J Held","year":"2013","unstructured":"Held J, Kohlberger I, Rappold E, Busse Grawitz A, Hacker G. Comparison of (1->3)-beta-D-glucan, mannan\/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia. J Clin Microbiol. 2013;51:1158\u201364.","journal-title":"J Clin Microbiol"},{"key":"2481_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2253-14-9","volume":"14","author":"A Cortegiani","year":"2014","unstructured":"Cortegiani A, Russotto V, Montalto F, Foresta G, Accurso G, Palmeri C, et al. Procalcitonin as a marker of Candida species detection by blood culture and polymerase chain reaction in septic patients. BMC Anesthesiol. 2014;14:9.","journal-title":"BMC Anesthesiol"},{"key":"2481_CR31","doi-asserted-by":"publisher","first-page":"701480","DOI":"10.1155\/2015\/701480","volume":"2015","author":"C Leli","year":"2015","unstructured":"Leli C, Ferranti M, Moretti A, Dhahab Al ZS, Cenci E, Mencacci A. Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections. Dis Markers. 2015;2015:701480.","journal-title":"Dis Markers"},{"key":"2481_CR32","first-page":"230","volume":"23","author":"F Miglietta","year":"2015","unstructured":"Miglietta F, Faneschi ML, Lobreglio G, Palumbo C, Rizzo A, Cucurachi M, et al. Procalcitonin, C-reactive protein and serum lactate dehydrogenase in the diagnosis of bacterial sepsis, SIRS and systemic candidiasis. Infez Med. 2015;23:230\u20137.","journal-title":"Infez Med"},{"key":"2481_CR33","first-page":"e1774","volume":"94","author":"A Oussalah","year":"2015","unstructured":"Oussalah A, Ferrand J, Filhine-Tresarrieu P, Aissa N, Aimone-Gastin I, Namour F, et al. Diagnostic accuracy of procalcitonin for predicting blood culture results in patients with suspected bloodstream infection: an observational study of 35,343 consecutive patients (a STROBE-compliant article). Med Wolters Kluwer Health. 2015;94:e1774.","journal-title":"Med Wolters Kluwer Health"},{"key":"2481_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/1735-1995.183996","volume":"21","author":"S Li","year":"2016","unstructured":"Li S, Rong H, Guo Q, Chen Y, Zhang G, Yang J. Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis. J Res Med Sci. 2016;21:39.","journal-title":"J Res Med Sci"},{"key":"2481_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13054-017-1763-5","volume":"21","author":"DR Giacobbe","year":"2017","unstructured":"Giacobbe DR, Mikulska M, Tumbarello M, Furfaro E, Spadaro M, Losito AR, et al. Combined use of serum (1,3)-beta-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units. Crit Care. 2017;21:176.","journal-title":"Crit Care"},{"key":"2481_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s11739-017-1627-7","volume":"12","author":"F Pieralli","year":"2017","unstructured":"Pieralli F, Corbo L, Torrigiani A, Mannini D, Antonielli E, Mancini A, et al. Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit. Intern Emerg Med. 2017;12:629\u201335.","journal-title":"Intern Emerg Med"},{"key":"2481_CR37","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ajem.2016.12.017","volume":"35","author":"ST Yan","year":"2017","unstructured":"Yan ST, Sun LC, Jia HB, Gao W, Yang JP, Zhang GQ. Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria. Am J Emerg Med. 2017;35:579\u201383.","journal-title":"Am J Emerg Med"},{"key":"2481_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s13054-018-2183-x","volume":"22","author":"M Bassetti","year":"2018","unstructured":"Bassetti M, Russo A, Righi E, Dolso E, Merelli M, Cannarsa N, et al. Comparison between procalcitonin and C-reactive protein to predict blood culture results in ICU patients. Crit Care. 2018;22:252.","journal-title":"Crit Care"},{"key":"2481_CR39","first-page":"3130","volume":"22","author":"R Murri","year":"2018","unstructured":"Murri R, Mastrorosa I, Taccari F, Baroni S, Giovannenze F, Palazzolo C, et al. Procalcitonin is useful in driving the choice of early antibiotic treatment in patients with bloodstream infections. Eur Rev Med Pharmacol Sci. 2018;22:3130\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2481_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13054-018-2050-9","volume":"22","author":"DO Thomas-Ruddel","year":"2018","unstructured":"Thomas-Ruddel DO, Poidinger B, Kott M, Weiss M, Reinhart K, Bloos F. Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia. Crit Care. 2018;22:128.","journal-title":"Crit Care"},{"key":"2481_CR41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jmii.2014.06.009","volume":"48","author":"S He","year":"2015","unstructured":"He S, Hang J-P, Zhang L, Wang F, Zhang D-C, Gong F-H. A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-beta-D-glucan for invasive fungal infection: focus on cutoff levels. J Microbiol Immunol Infect. 2015;48:351\u201361.","journal-title":"J Microbiol Immunol Infect"}],"updated-by":[{"DOI":"10.1186\/s13054-019-2598-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000}}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2481-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-019-2481-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2481-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T23:25:09Z","timestamp":1590535509000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-019-2481-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2481"],"URL":"https:\/\/doi.org\/10.1186\/s13054-019-2481-y","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13054-019-2598-z","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"8 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author wish to note there are three imprecisions in the article [1].","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"IML received fees for lectures from Thermofisher, Polyphor, J&J, Virogates, and MSD and advisory board from Fresenius Kabi, MaaT Pharma, Bayer, Gilead, Clinigen, Biotest, and Accelerate (all unrelated to the present work). AG received fees for consultancies or lectures from Orion, Pfizer, and MSD (all unrelated to the present work). MB has received funding for scientific advisory boards and travel and speaker honoraria from Angelini, AstraZeneca, Bayer, Biomerieux, Cidara, Cubist, Gilead, Pfizer, Melinta Therapeutics, Menarini, MSD, Nabriva, Paratek, Roche, Shionogi, Tetraphase, The Medicines Company, and Astellas Pharma Inc. (all unrelated to the present work). All other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}